Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
POLYMEDIX, INC (PYMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/28/2011 BW PolyMedix Presents Data Showing Antimicrobial Activity of Sutures Containing PolyCide
05/25/2011 BW PolyMedix Presents Antimicrobial Compound Data at Two Prestigious Scientific Meetings
05/19/2011 BW PolyMedix PMX-30063 Defensin-Mimetic Antibiotic Compound Shows Promising Activity for Oral Mucositis
05/17/2011 BW PolyMedix to Present at the UBS Conference
05/16/2011 BW PolyMedix to Present at the Noble Financial Equity Conference
05/03/2011 BW PolyMedix Presents Data on PMX-60056 at the American Heart Association ATVB-2011 Meeting
04/26/2011 BW PolyMedix Defensin-Mimetic Antibiotics Show Activity in A Respiratory Infection Model Against Anthrax
04/06/2011 BW PolyMedix Prices $20 Million Underwritten Offering
03/02/2011 BW PolyMedix to Present at the Cowen 31st Annual Health Care Conference
02/24/2011 BW PolyMedix Successfully Completes Phase 1 Exposure Escalation Safety Study With PMX-30063 Antibiotic
12/07/2010 BW PolyMedix Presents PMX-60056 Clinical Data at American Society of Hematology Meeting
11/29/2010 BW PolyMedix to Present at the NYSSA Biotech and Specialty Pharmaceutical Conference
11/23/2010 BW PolyMedix Expands Research Science Advisory Board
11/22/2010 BW Small-cap Biotech Executives Reveal Innovative Technologies at NYSSA Conference
11/22/2010 BW PolyMedix Announces Three Presentations at Upcoming American Society of Hematology Meeting
11/17/2010 BW PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
11/16/2010 BW PolyMedix and University of Massachusetts Receive $750,000 Contract from U.S. Army Research Office
11/15/2010 BW PolyMedix Presents PMX-60056 Clinical Data at the American Heart Association Scientific Sessions Meeting
11/09/2010 BW PolyMedix Antimicrobial and Anti-inflammatory Data Published in Molecular Oral Microbiology
11/08/2010 BW PolyMedix Organizes Infectious Disease Clinical Advisory Board
11/04/2010 BW PolyMedix Announces Acceptance of Two Presentations at the American Heart Association Meeting
11/03/2010 BW PolyMedix Awarded Therapeutic Discovery Credits for Two Lead Programs
10/26/2010 BW Small-cap Biotech Executives Reveal Innovative Technologies at NYSSA Conference
10/21/2010 BW PolyMedix Provides Updates on PMX-60056 Heptagonist Program
10/20/2010 BW PolyMedix to Present at the BioCentury NewsMakers in the Biotech Industry Conference
09/30/2010 BW PolyMedix Receives Phase 2 NIH Grant to Develop a Novel Antimicrobial Defensin Mimetic for Oral Candidiasis
09/28/2010 BW PolyMedix Initiates Phase 2 Clinical Trial with Novel Antibiotic, PMX-30063
09/15/2010 BW PolyMedix Presents Antibiotic Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
09/15/2010 BW PolyMedix to Present at the UBS Global Lifesciences Conference
09/08/2010 BW PolyMedix to Present Antibiotic Data at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
08/11/2010 BW PolyMedix Successfully Completes Phase 1B/2 Heparin Dose-Ranging Study with PMX-60056 Heptagonist
07/07/2010 BW PolyMedix Receives NIH Grant to Develop New Antimicrobials for the Treatment of Malaria
06/03/2010 BW PolyMedix Successfully Completes Phase 1B Clinical Study to Reverse Low Molecular Weight Heparin with PMX-60056
05/10/2010 BW PolyMedix to Present at the Rodman and Renshaw Annual Global Investment Conference
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy